What's new

PRAC concludes eye condition NAION is a very rare side effect of semaglutide medicines Ozempic, Rybelsus and Wegovy

PRAC concludes eye condition NAION is a very rare side effect of semaglutide medicines Ozempic, Rybelsus and Wegovy

Jun 6, 2025 - 12:20
 0
PRAC concludes eye condition NAION is a very rare side effect of semaglutide medicines Ozempic, Rybelsus and Wegovy
PRAC concludes eye condition NAION is a very rare side effect of semaglutide medicines Ozempic, Rybelsus and Wegovy
Read More

Tags:

Previous Article

EMEA-003405-PIP01-23

Next Article

The ‘buy-American’ push is backfiring

Related Posts

Human medicines European public assessment report (EPAR): Conexxence, denosumab, Status: Opinion

Human medicines European public assessment report (EPAR...

May 23, 2025  0

Human medicines European public assessment report (EPAR): Lucentis, ranibizumab, Date of authorisation: 22/01/2007, Revision: 46, Status: Authorised

Human medicines European public assessment report (EPAR...

May 12, 2025  0

European Shortages Monitoring Platform (ESMP) Informati...

May 13, 2025  0